Start New EnglishEspañol中文РусскийالعربيةTiếng ViệtFrançaisDeutsch한국어Tagalog Library Performance
BETA v.3.0

2025 ICD-10-CM code J84.89

Other specified interstitial pulmonary diseases. This includes conditions like endogenous lipoid pneumonia, interstitial pneumonitis, and non-specific interstitial pneumonitis NOS.

Follow ICD-10-CM coding guidelines. If a respiratory condition occurs in more than one site and is not specifically indexed, classify it to the lower anatomic site.For drug-induced interstitial lung disease, also assign codes from categories T36-T50 to identify the drug.

Medical necessity should be established by documenting the signs, symptoms, and diagnostic findings that support the diagnosis of interstitial lung disease. The documentation should also indicate the severity of the condition and its impact on the patient's respiratory function.

The clinician is responsible for diagnosing the specific interstitial lung disease and documenting the findings that support the diagnosis. This includes imaging studies, pulmonary function tests, and possibly lung biopsy.

IMPORTANT:Consider other codes in the J84 series for other interstitial lung diseases. Consider codes T36-T50 for drug-induced pneumonitis, codes J60-J70 for lung diseases due to external agents, and codes T51-T65 if there is poisoning due to drug or toxin.

In simple words: This code refers to other specific types of interstitial lung diseases.Interstitial lung diseases affect the tissue and space around the air sacs of the lungs.Some examples included in this code are endogenous lipoid pneumonia, interstitial pneumonitis, and organizing pneumonia.

This code represents other specified interstitial pulmonary diseases, including endogenous lipoid pneumonia, interstitial pneumonitis, non-specific interstitial pneumonitis NOS, and organizing pneumonia NOS. If applicable, code first any poisoning due to drug or toxin (T51-T65 with fifth or sixth character to indicate intent) for toxic pneumonopathy, or the underlying cause of pneumonopathy if known. Use an additional code for adverse effect to identify the drug (T36-T50 with fifth or sixth character 5) if drug-induced. Excludes1: cryptogenic organizing pneumonia (J84.116), idiopathic non-specific interstitial pneumonitis (J84.113), lipoid pneumonia (exogenous or unspecified) (J69.1), and lymphoid interstitial pneumonia (J84.2).

Example 1: A patient presents with shortness of breath and cough. Imaging reveals findings consistent with interstitial pneumonitis, but the cause is not identified. J84.89 is used., A patient with a history of rheumatoid arthritis develops interstitial lung disease. After extensive workup, the specific type of interstitial lung disease cannot be determined. J84.89 is used., A patient develops organizing pneumonia following a COVID-19 infection. J84.89 is used, along with the appropriate code for the post-COVID condition (e.g., U09.9).

Documentation should include the type of interstitial lung disease, clinical findings (symptoms, physical exam), results of diagnostic tests (imaging, pulmonary function tests, biopsy if performed), and any associated conditions.

** For post-COVID conditions, use the appropriate code in category U09. Ensure documentation clearly distinguishes this code from other, more specific interstitial lung diseases.

** Only Enterprise users with EHR integration can access case-specific answers. Click here to request access.

Discover what matters.

iFrame™ AI's knowledge is aligned with and limited to the materials uploaded by users and should not be interpreted as medical, legal, or any other form of advice by iFrame™.